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Metabolic adaptation is a key component of macrophage plasticity and polarization, instrumental to their
function in homeostasis, immunity, and inflammation.Macrophageproducts also impactmetabolism, as illus-
trated by obesity-associated pathologies. Defining the mechanisms regulating macrophage metabolic
activity andorchestration ofmetabolismbymacrophages is crucial to pathology and therapeutic intervention.Introduction
Metabolism is a key component of the function of cells of the
immune system, well beyond its role in energy generation for
cellular and tissue building purposes. Differential metabolic
orientation is essential for the function of cells of the innate and
adaptive immune system (Odegaard and Chawla, 2011; Olefsky
and Glass, 2010). Monocytes and macrophages are essential
components of innate immunity and represent the first line of
defense against pathogens.Moreover,mononuclear phagocytes
fulfill a variety of homeostatic functions, which go beyond host
defense and include tissue remodeling in embryogenesis, wound
healing, aswell asorchestrationof, andcontribution to,metabolic
activity (Odegaard and Chawla, 2011). It has long been known
that macrophage function and metabolism are connected. For
instance, glutamine and L-arginine metabolism has been recog-
nized to be involved in macrophage functions like nitric oxide
(NO) production, microbicidal activity, and phagocytosis. More-
over, a role for these cells in the pathogenesis of insulin-depen-
dent diabetes was proposed (Murphy and Newsholme, 1997).
Along the same line, TNF was also discovered as a macro-
phage-derived factor causing cachexia (Beutler et al., 1985).
Studies over the last few years have resurrected these ‘‘old
connections’’ with further molecular and genetic approaches.
In response to signals derived from microbes, damaged
tissues, or activated lymphocytes (Biswas and Mantovani,
2010), cells of the monocyte-macrophage lineage undergo re-
programming with the emergence of a spectrum of distinct
functional phenotypes. These functional phenotypes serve
various tasks ranging from host protection to reinstating homeo-
stasis. Transcriptomic and molecular characterization of macro-
phages in vitro have revealed distinct immune signatures
related to their functional phenotypes (Martinez et al., 2006).
Evidence now suggests that metabolism is an important deter-
minant of the functional phenotype acquired by macrophages
under the influence of cues derived from tissue microenviron-
ment, under physiological and pathological conditions. Here,
we review key aspects of metabolism in macrophage function
and polarized activation and how these cells in turn are an essen-
tial component in the orchestration of metabolism in pathology.
The reader is referred to a previous review on macrophages as
a background and framework of the present essay (Biswas
and Mantovani, 2010).432 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.Macrophage Polarization
Functional diversity is a hallmark of the mononuclear phagocyte
system. Macrophages respond to diverse environmental signals
by expressing an array of functional phenotypes. Despite this
diversity, two distinct macrophage activation states have been
recognized, namely, the M1 (or classically activated) macro-
phages and the M2 (or alternative activated) macrophages
(Biswas and Mantovani, 2010) (Figure 1). Exposure to inter-
feron-g (IFNg) and Toll-like receptor (TLR) ligands polarizes
macrophages into the proinflammatory, M1 phenotype, which
is characterized by the expression of proinflammatory cytokines,
inducible nitric oxide synthase (iNOS or NOS2), reactive nitrogen
intermediates (RNI), reactive oxygen species (ROS), promotion
of Th1 responses, and strong microbicidal and tumoricidal
activity. In contrast, IL-4- and IL-13-polarized (M2) macrophages
help in parasite clearance, dampen inflammation, promote
tissue remodeling, tumor progression, and possess immunoreg-
ulatory functions. They are characterized by increased phago-
cytic activity, high expression of scavenging, mannose and
galactose receptors, production of ornithine and polyamines
through the arginase pathway, a distinct chemokine repertoire
(e.g., CCL17, CCL18 and CCL22) and an IL-12loIL-10hiIL-1 de-
coyRhiIL-1RAhi phenotype (Biswas and Mantovani, 2010). Other
stimuli like IL-10 and immune complexes also polarize macro-
phages to an M2-like phenotype with immunoregulatory and
protumoral functions (Biswas and Mantovani, 2010). Macro-
phages showing such M2-like phenotype share to variable
extents properties of IL-4-activated macrophages, including
high expression of scavenging and mannose receptors and
high IL-10 production. Interestingly, in the myelomonocytic
differentiation pathway, neutrophils have now been shown to
exhibit unsuspected plasticity and integration into circuits of
innate and adaptive immunity (Mantovani et al., 2011). Whether
and to what extent these relatives of monocytes impact on
metabolism and metabolic diseases remains to be determined.
The canonical M1 and M2 activation states have been defined
in vitro using conventional approaches and transcriptional pro-
filing (Martinez et al., 2006). Functional polarization has now
been observed in vivo under physiological and pathological
conditions. Under conditions such as parasite infections, allergy,
and many tumor types, the functional phenotypes of macro-
phages in vivo mirror those of canonical M1, M2, or M2-like
Figure 1. Orchestration of Metabolism by Macrophages
Italicized words indicate macrophage-mediated functions related to metabolic activities. Red, associated diseases. Inset: Selected metabolic features of
polarized macrophages. See the main text for details.
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some settings (e.g., in the placenta and embryo, in adipose
tissue during obesity, and in certain cancers) this is not the
case, and macrophage population express a mixed or unique
phenotype (reviewed in Biswas and Mantovani, 2010). Such
macrophage phenotypes may be a result of the diversity of
tissue-derived microenvironment signals, the coexistence of
cellular subpopulations with different phenotypes in the same
tissue, and the dynamic changes during disease progression.
These studies emphasize the heterogeneity and plasticity of
macrophage functional states, indicating that M1 andM2 activa-
tion states are not ontogenetically defined subsets but the
extremes of a continuum of functional phenotypes (Biswas and
Mantovani, 2010).
Metabolism in Macrophage Activation and Function
The macrophage-metabolism connection has two faces
(Figure 1): on one hand, macrophages exert an ‘‘extrinsic’’ regu-
latory function on metabolic functions, for instance by releasing
inflammatory cytokines; on the other hand, ‘‘intrinsic’’ metabolicfunctions of these cells contribute to the shaping of their activa-
tion state (Figure 1, inset). The latter aspect is the focus of this
section of the present review.
Glucose Metabolism
Polarized macrophages show a distinct regulation of glucose
metabolism. Macrophages in response to IFNg or TLR ligands
display a metabolic shift toward the anaerobic glycolytic
pathway, while IL-4 has little effect (Rodrı´guez-Prados et al.,
2010). The higher glycolytic flux in IFNg/LPS-activated macro-
phages involves a switch in the expression of 6-Phospho-
fructo-2-kinase (PFK2) isoforms from the liver-type PFK2
(L-PFK2) to the more active and ubiquitous PFK2 isoform
(uPFK2), which maintains higher Fructose-2,6-biphosphate
concentrations.
Increased glycolysis in M1-polarized macrophages is permis-
sive to quickly trigger microbicidal activity and cope with a
hypoxic tissue microenvironment. In this scenario, an anaerobic
process like glycolysis is best suited to meet their rapid
energy requirements. In contrast, oxidative glucose metabolism
(fatty acid oxidation), the metabolic pathway of choice inCell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc. 433
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tissue remodeling and repair (Odegaard and Chawla, 2011).
Notably, M2-polarized macrophages are known to contribute
to tissue remodeling, repair, and wound healing under patho-
physiological conditions (Biswas and Mantovani, 2010). Further-
more, aerobic and anaerobic glucose metabolism also fuel
phagocytosis, which is an energy-demanding process and a
key property of polarized macrophages.
Lipid Metabolism
Lipidomics has added another dimension to our understanding
of the plasticity of lipid metabolism during macrophage activa-
tion (Dennis et al., 2010). In particular, polarization of human
macrophages was associated with differential regulation of
sphingolipid mediators, sphingosine, and ceramide kinases
(Martinez et al., 2006). IL-4-activated M2 mouse macrophages
show a significant upregulation of fatty acid uptake and fatty
acid oxidation, which are suppressed in M1 macrophages (Ode-
gaard and Chawla, 2011). Lipid metabolism also contributes
to macrophage phagocytosis by fulfilling its energetic needs
and regulating membrane fluidity necessary for this process.
In fact, saturated and unsaturated fatty acids differentially
modulate macrophage phagocytosis.
Macrophages are an important source of lipid mediators that
orchestrate inflammation and its resolution. Differential gene
regulation of arachidonate metabolism related enzymes has
been reported in M1- and M2-polarized human macrophages
(Martinez et al., 2006). IFNg/LPS-activated M1 macrophages
showed a marked induction of COX2, with downregulation of
COX1, leukotriene A4 hydrolase, thromboxane A synthase 1,
and arachidonate 5-lipoxygenase (ALOX5). Conversely, IL-4-
activated M2 macrophages showed an upregulation of arachid-
onate 15-lipoxygenase and COX1. Similarly, the microsomal
isoform of PGE synthase (mPGES) is induced in macrophages
by TLR engagement and is functionally coupled to COX2 expres-
sion. In contrast, IL-4 and IL-13 downregulate the expression of
mPGES in macrophages (Mosca et al., 2007). Thus, in response
to microenvironmental signals, macrophages can profoundly
alter their lipid profile and the production of lipid mediators
involved in the activation and resolution of inflammation.
Amino Acid Metabolism
L-arginine (L-Arg) metabolism is regulated in polarized macro-
phages via two enzymes, Nitric Oxide Synthase 2 (NOS2 or
iNOS) and Arginase 1 (liver type, ARG1). NOS2 metabolizes
L-Arg to nitric oxide (NO) and L-citrulline, while Arginase
metabolizes L-Arg to ornithine and urea, which is then used in
the urea cycle. M1 macrophages are characterized by the
expression of NOS2 and the production of NO, which is an
important effector of their microbicidal activity. In contrast,
mouse, but not human, IL-4-activatedM2macrophages express
high levels of ARG1, which catalyzes polyamine production
necessary for collagen synthesis, cell proliferation, and tissue
remodeling.
L-arginine-derived metabolites, cysteine/cysteine, and tryp-
tophan metabolism (via indoleamine 2, 3-dioxygenase) are
important mediators of the immunosuppressive activity of
myeloid-derived suppressor cells (MDSCs). Similarly, intracel-
lular nicotinamide adenine dinucleotide (NAD), an endproduct
of tryptophan metabolism, has been demonstrated as an impor-
tant regulator of inflammatory cytokines like TNF and IL-6 in434 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.mononuclear phagocytes, with implications in various patholo-
gies (Van Gool et al., 2009).
Iron Metabolism
Macrophages play an important role in iron homeostasis by recy-
cling iron through phagocytosis of senescent red blood cells and
rendering it available for processes like erythropoiesis. Mouse
and humanmacrophage polarization is associated with differen-
tial regulation of iron metabolism (Cairo et al., 2011). IL-4-acti-
vated macrophages expressed high levels of CD163 and CD94
(heme uptake), low Ferritin (iron storage), and high Ferroportin
(iron export). The high levels of intracellular heme pool together
with induction of heme oxygenase result in production of CO,
which has immunosuppressive activity. In contrast, IFNg-acti-
vated macrophages show a CD163lowFerritinhighFerroportinlow
phenotype. Thus, M2-polarized macrophages are set in an
iron-export mode that supports immunoregulation, promotion
of matrix remodeling, and cell proliferation. Conversely, M1-
polarized macrophages are set in an iron-retention mode
that supports bacteriostatic and tumoristatic activity. Proteins
like Hepcidin and human hemochromatosis protein (HFE)
contribute to the iron homeostasis in macrophages by degrading
ferroportin, which results in inhibition of iron release (Cairo et al.,
2011). Thus, iron handling has emerged as a key property of
macrophage polarized activation with broad implications in
immunopathology.
Glutathione and Redox Metabolism
IFNg and IL-4 drive murine macrophages to a ‘‘reductive’’ and
‘‘oxidative’’ mode, characterized by high and low glutathione
levels, respectively (Murata et al., 2002). Further, redox metabo-
lism regulates macrophage response in parasitic infections.
A redox enzyme (rTgPrx) derived from Toxoplasma gondii was
shown to drive M2 polarization of macrophages and promote
parasite replication (Marshall et al., 2011). Thus, glutathione
and redox metabolism seem to have an important contribute in
macrophage polarization and its functions.
Pathology
Obesity, Insulin Resistance, Diabetes,
and Atherosclerosis
Obesity-induced chronic inflammation is critical in the pathogen-
esis of insulin resistance, diabetes, and metabolic syndrome.
Adipose tissue is mainly composed of adipocytes, adipose
tissue macrophages (ATMs), lymphocytes, and endothelial cells.
Under normal conditions, adipocytes release factors such as
leptin and adiponectin that promote insulin sensitivity. In con-
trast, during obesity, adipocytes release proinflammatory
factors like CCL2, TNF, or free fatty acids (FFAs) that induce
the recruitment and activation of ATMs (Olefsky and Glass,
2010). ATMs, in turn, through the release of inflammatory cyto-
kines (e.g., TNFa, IL-6, IL-1b, Migration inhibitory factor, Resis-
tins), amplify this inflammatory circuit which blocks insulin action
on adipocytes, leading to insulin resistance.
Profiling of ATMs from obese mice showed them to express
M1-like characteristics such as upregulation of inflammatory
markers (TNF and iNOS), while those from lean mice expressed
M2-related markers such as Il10, Ym1, and Arg1 (Lumeng et al.,
2007). ATMs are a heterogeneous population. The majority
of the inflammatory ATMs in obese mice expressed an
F4/80+CD11b+CD11c+ phenotype, whereas a minor proportion
Figure 2. Signaling Pathways Connecting Macrophage Polarization to Metabolic Outcomes
IFNg and LPS signal through the IFNAR1 and TLR4 and activate the transcription factors NF-kB (via IKKb), AP1, IRF3, and STAT1, leading to the transcription of
M1 genes. Expression of the inflammatory cytokine IL-1b via inflammasome activation by endogenous danger signals and ER stress is also indicated. In contrast,
M2 stimuli such as IL-4 and IL-13 signal through IL-4 receptor (IL-4R) to activate STAT6, which regulates the expression of M2 genes. Regulation of these genes
also involves KLF4, PPARg, and IRF4, as well as the histone demethylase Jumonji domain-containing 3 (JMJD3). Molecular pathways involved in M2-like
polarization by other signals (e.g., immune complexes) are not shown here.
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displayed M2-like features (e.g., high IL-10) (Nguyen et al.,
2007). A recent study reported that during chronic weight loss
in animals, F4/80+CD11c–CD301+ macrophages with M2-like
characteristics were recruited to the adipose tissue, where
they possibly mediated lipolysis (Kosteli et al., 2010). Although
the function of M2-like ATMs needs further investigation, these
cells may be involved in maintaining adipose tissue homeostasis
by preventing inflammation and promoting insulin sensitivity,
whereas the inflammatory ATMs would drive obesity-induced
inflammation and insulin resistance. A similar situation has also
been suggested for Kupffer cells (the resident macrophages
in liver), wherein polarized response of these cells affect metab-
olism and insulin sensitivity of hepatocytes with implications
for fatty liver disease and insulin resistance (Odegaard and
Chawla, 2011).
The TLR and inflammasome pathways have been suggested
to drive low-grade inflammation in obesity-related metabolic
diseases. Saturated FFAs or elevated glucose levels activate
TLRs in macrophages and adipocytes, triggering an inflamma-tory cascade (Masters et al., 2011) (Figure 2). TLR signaling in
adipocytes causes serine phosphorylation of key components
in the insulin signaling pathway (e.g., insulin receptor substrate
[IRS]) and its inhibition. TLR4 has been reported to be upregu-
lated in macrophages during obesity, while its gene deletion
in hematopoietic cells resulted in an impaired inflammatory
response to saturated FFAs and protection against insulin resis-
tance (Nguyen et al., 2007; Olefsky and Glass, 2010). While the
role of TLR4 in high fat diet-induced insulin resistance has
been demonstrated with TLR4 whole-body knockout (KO),
hematopoietic cell-specific KO, and LPS-resistant mouse
strains, a divergent effect on body weight composition, an
important factor impacting insulin resistance, was noted.
Although the reasons for such differences remain unclear, differ-
ences in mouse strains or TLR4 mutations may be possible
contributing factors. Further, the contribution of TLR4 expres-
sion on other cell types in insulin resistance also remains to be
clarified.
FFAs, elevated glucose levels, and oligomers of islet amyloid
polypeptide are reported to activate the NOD-like receptorCell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc. 435
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pathway (Masters et al., 2011) (Figure 2). Activation of NLRP3
leads to caspase-1 expression and secretion of IL-1b, which
mediate decreased insulin sensitivity. IL-1b blocks insulin
signaling in target cells through activation of inflammatory
signaling and the production of SOCS proteins. In addition,
IL-1b triggers cytotoxicity and death of b cells in the pancreas.
Mice genetically deficient for NLRP3, caspase-1, and IL-1b
provided strong evidence for the role of the NLRP3 inflamma-
some pathway in the development of insulin resistance and
diabetes (Masters et al., 2011).
Inflammatory responses triggered by IL-1b, TNFa, and TLR
ligands are mediated by the transcription factor NF-kB. NF-kB
activation inhibited insulin signaling in adipocytes, while its
inactivation in myeloid cells with a myeloid-specific deletion of
IKKb protected animals from obesity-induced insulin resistance
(Baker et al., 2011). The nuclear receptor peroxisome prolifera-
tor-activated receptor-g (PPARg) and the transcriptional factor
Kru¨ppel-like factor 4 (KLF4) have been recently linked to M2
macrophage polarization. Studies in mice with selective gene
inactivation in macrophages showed these molecules to inhibit
inflammatory response to FFAs and block the development of
obesity-induced insulin resistance (Liao et al., 2011; Odegaard
and Chawla, 2011). A similar role has been reported for PPARd
using macrophage specific KO and bone marrow chimeras
(Odegaard and Chawla, 2011). However, another study using
bone marrow chimeras for PPARg or d (or both) in a different
mouse strain showed no major impact on obesity and insulin
resistance, emphasizing the importance of the genetic back-
ground (Marathe et al., 2009). The fact that PPARg is a target
for drugs like Thiazolidinediones in diabetes and that KLF4
expression is markedly reduced in the adipose tissue of obese
human subjects (Liao et al., 2011) emphasizes their potential
relevance in human insulin resistance and diabetes. Based on
current evidence, it may be possible that PPARg, KLF4,
STAT6, and interferon-responsive factor 4 (IRF4) may be instru-
mental in orchestrating the metabolic functions of M2-like
macrophages at the mechanistic level (Liao et al., 2011)
(Figure 2).
Macrophagesaremajor players in atherosclerosis, apathology
epidemiologically linked to obesity. Macrophages through the
uptake of oxidized lipids develop into foam cells and release
inflammatory mediators that cause low-grade inflammation in
the arterial wall (Moore and Tabas, 2011). Importantly, the activa-
tion state of macrophages is a determinant of plaque stability
and rupture. Sensing of cholesterol crystals and oxidized lipids
leads to the activation of TLRs, inflammasomes, and LXRs that
constitute key molecular pathways orchestrating macrophage
function in atherosclerosis. The readers are referred to dedicated
reviews for a detailed and critical discussion of this field (Moore
and Tabas, 2011)
Diseases Related to Iron Metabolism
In chronic venous leg ulcers, evidence in mice and patients sug-
gested that iron overloading skews macrophages toward an
unrestrained proinflammatory M1-like phenotype that sustains
tissue damage and impairs wound healing (Sindrilaru et al.,
2011). Macrophage-derived ROS was suggested to mediate
DNA damage, fibroblast cellular senescence, and defective
tissue repair in this disease. It is tempting to speculate that436 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.similar mechanisms may underlie M2-like skewing in burnt
patients.
Hereditary hemochromatosis is a genetically determined iron
overload disease, associated with a defect in the hemochroma-
tosis gene, Hfe. In fact, in macrophages fromHfe knockout mice,
lower intracellular iron correlated with a reduced inflammatory
cytokine response to LPS and an impaired innate immune
response, as observed in patients with defects in iron homeo-
stasis (Cairo et al., 2011).
Hypoxia
Hypoxia is a common tissue microenvironmental condition
associated with infection, cancer, and obesity. Macrophages
respond to hypoxia by activation of the transcription factor
hypoxia-inducible factor (HIF). HIF expression can regulate not
only inflammation, but also anaerobic energy metabolism in
macrophages (Imtiyaz and Simon, 2010). In addition, HIF iso-
forms (HIF1a and HIF2a) have been shown to affect
the polarization of macrophages by differentially modulating
L-arginine response. Thus, in the hypoxic adipose tissues, it is
likely that expression of HIF isoforms in macrophages could
contribute to their polarization, low-grade inflammatory re-
sponse, and development of insulin resistance. Similarly, in
atherosclerosis, hypoxia-induced CXCL8 expression in foam
cells is an important factor for plaque development (Imtiyaz
and Simon, 2010). More recently, another oxygen sensor,
PHD2, was shown to regulate arteriogenesis by controlling
macrophage polarization, thereby raising alternative treatment
options for ischemic disorders in diabetic or hypercholesterol-
emic patients (Takeda et al., 2011).
Concluding Remarks
Metabolic adaptation is an integral aspect of macrophage
polarization and their functional plasticity. Macrophages, in turn,
through theexpressionof differentmediators, orchestrate various
aspects ofmetabolism and the development ofmetabolic pathol-
ogies. Progress has beenmade in defining the genetic and epige-
netic networks that underlie macrophage activation including
their involvement in the orchestration of metabolism (Figure 1).
Moreover, regulation of macrophage function has emerged as
an ‘‘off target’’ effect of PPARg agonists and statins, possibly
being an important determinant of therapeutic effectiveness.
Defining the actual clinical significance ofmacrophage regulation
by these agents may provide further correlates of activity and
better tailoring of therapy. Macrophage-targeting therapeutic
strategies (e.g., antibodies or simple chemicals against CSF-1,
CCL2, and their cognate receptors) are undergoing preclinical
and clinical evaluation. It will be important to assess their impact
on metabolic functions as information at this level may impact on
their clinical use. A better understanding of the macrophage
‘‘metabolic connection’’ and macrophage polarization in vivo
may provide a basis for the development or better exploitation
of targeted and ‘‘off target’’ therapeutic strategies.
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